Usefulness of serum HE4 in endometriotic cysts

British Journal of Cancer

Volumn 101, Issue 3, 2009, Pages 548-

  Montagnana, M ^a   Lippi, G ^a   Danese, E ^a   Franchi, M ^a   Guidi, G C ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; HUMAN EPIDIDYMAL PROTEIN 4; ONCOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY CANCER; ENDOMETRIOSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; OVARY CANCER; OVARY CYST; OVARY ENDOMETRIOTIC CYST; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; ROC CURVE;

CA-125 ANTIGEN; ENDOMETRIOSIS; EPIDIDYMAL SECRETORY PROTEINS; FEMALE; HUMANS; OVARIAN CYSTS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 68149149082     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605119     Document Type: Letter

References (3)

1. Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, Setälä M, Härkki P, Jalkanen J, Fraser J, Mäkinen J, Auranen A, Poutanen M, Perheentupa A (2009) Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer 100(8): 1315-1319
2. Muyldermans M, Cornillie FJ, Koninckx PR (1995) CA125 and endometriosis. Hum Reprod Update 1: 173-187
3. Moore RG, Brown AK, Miller MC, Skates S, Allard WJ, Verch T, Steinhoff M, Messerlian G, DiSilvestro P, Granai CO, Bast Jr RC (2008) The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol 108: 402-408